TUMOR SUPPRESSOR VSTM2A AS A BIOMARKER FOR COLORECTAL CANCER
A kit and device useful for such a method are also provided. In addition, the present invention provides a method for treating colorectal cancer by increasing VSTM2A gene expression or activity.Jun YuJoseph Jao Yiu SungSimon Siu Man Ng